Table 1 Baseline characteristics and contemporaneous measurements of the patients in this study
Complete study (N = 32) | Incomplete study (N = 8) | |
|---|---|---|
Age (years) | 56.3 ± 12.7 | 55.3 ± 11.8 |
Female (N, %) | 25 (78.1 %) | 5 (62.5 %) |
BMI (Kg/m2) | 23.7 ± 3.2 | 23.8 ± 2.9 |
BMI > 25 (N, %) | 10 (31 %) | 3 (37.5 %) |
SBP (mmHg) | 130.6 ± 15.5 | 130.9 ± 15.6 |
DBP (mmHg) | 79.2 ± 8.7 | 79.5 ± 8.8 |
History of smoking (N, %) | 5 (15.6 %) | 1 (12.5 %) |
Hypertension (N, %) | 24 (75 %) | 6 (75 %) |
Hypertension before 35 year old | 2 (6.3 %) | 1 (12.5 %) |
Hypertension after 35 year old | 22 (68.8 %) | 5 (62.5 %) |
Antihypertensive medication (N, %) | ||
ARB or ACE inhibitors | 19 (59.4 %) | 5 (62.5 %) |
Calcium channel blockers | 12 (37.5 %) | 3 (37.5 %) |
History of gross hematuria from ruptured cysts (N, %) | 4 (12.5 %) | 1 (12.5 %) |
History of infected cysts (N, %) | 7 (21.9 %) | 2 (25 %) |
Fasting blood sugar (mg/dL) | 96.6 ± 9.0 | 95.4 ± 8.6 |
LDL cholesterol (mg/dL) | 109.2 ± 28.1 | 110.3 ± 29.8 |
Serum uric acid (mg/dL) | 6.01 ± 1.26 | 6.11 ± 1.29 |
Serum albumin (g/L) | 37.7 ± 6.9 | 37.6 ± 5.1 |
Serum creatinine (mg/dL) | 0.94 ± 0.39 | 0.96 ± 0.36 |
eGFR: CKD-EPI (mL/min/1.73 m2) | 80.3 ± 24.9 | 79.8 ± 24.8 |
mGFR (mL/min/1.73 m2) | 83.8 ± 26.1 | 80.7 ± 24.0 (N = 2) |
htTKV (mL/m) | 681.0 ± 476.3 | 670.9 ± 452.7 (N = 3) |
Mayo imaging classificationa | ||
1 A (N, %) | 8 (25 %) | 1 (33.3 %) |
1B (N, %) | 11 (34.4 %) | 1 (33.3 %) |
1 C (N, %) | 9 (28.1 %) | 1 (33.3 %) |
1D (N, %) | 4 (12.5 %) | 0 |
1E (N, %) | 0 | 0 |
24-hr urine protein (mg/day/1.73 m2) | 205.5 ± 174.0 | 194.5 ± 177.5 (N = 2) |
24-hr urine albumin (mg/day/1.73 m2) | 79.0 ± 120.2 | 77.1 ± 85.2 (N = 2) |